Bionano Genomics, Inc.
USD1.14
+0.02 (+1.79%)
CEO
Robert Erik Holmlin
IPO Date
2018-08-21
Sector
Healthcare
Industry
Medical - Diagnostics & Research
Exchange
NASDAQ
Country
US
Open
$1.12
Prev. Close
$1.12
Day Low
$1.12
Day High
$1.15
52W Low
$1.06
52W High
$5.50
Market Cap
$0.01B
Volume
0.19M
| 27 |
| $1.30 |
| 3 Jun 2026 | Chaubey Alka | CHIEF MEDICAL OFFICER | F-InKind | Disposed | 24 | $1.30 |
| 3 Jun 2026 | Adamchak Mark | Principal Accounting Officer | F-InKind | Disposed | 7 | $1.30 |
| 14 May 2026 | Rajkovic Aleksandar | director | A-Award | Acquired | 9,149 | $1.19 |
| 14 May 2026 | Linney Yvonne | director | A-Award | Acquired | 9,149 | $1.19 |
| 14 May 2026 | Vuori Kristiina MD | director | A-Award | Acquired | 9,149 | $1.19 |
| 14 May 2026 | TWOMEY CHRISTOPHER J | director | A-Award | Acquired | 9,149 | $1.19 |
| 14 May 2026 | BARKER DAVID L | director | A-Award | Acquired | 9,149 | $1.19 |
| 18 Feb 2026 | Chaubey Alka | CHIEF MEDICAL OFFICER | F-InKind | Disposed | 18 | $1.10 |